(2), 167-183 -A food additive, furylfuramide or AF-2, which had been used in Japan since 1965 and structurally is composed of 5-nitro-2-furyl radical and acrylamide, was re-examined mainly on chronic toxicity by statistically reviewing published data. The conclusions are as follows: 1) The maximum safety dosage which shows no demonstrable change in rats must be corrected at least to 1/170 of the value which has been accepted by the Ministry of Health and Welfare of Japan (MHW).
2) The minimum effective dose to bacterial growth in food can not be lowered below the standard usage level which MHW determined, because the inactivation factor in food, decreasing effectivity to 1/20, must be taken into consideration.
3) In view of these two facts, AF-2 is found to be unacceptable as a food additive.
4) Great importance must also be attached to the possibility of mutagenicity and carcinogenicity of AF-2, pointed out recently. Both neurotoxicity and dermatitis observed in tofu (soybean curd) makers are also mentioned.
toxicity; food additive; nitrofuran; acrylamide; mutagenicity Because of the inhibiting power to bacterial growth, several 5-nitro-2-furyl compounds, such as nitrofurazon, nitrofurantoin and furazolidon, have been used as therapeutic medicine. There was an idea at one time, to use nitrofurazon as a food additive to inhibit bacterial growth, but FAO/WHO Committee expressed the opinion in 1966 that it cannot authorize this substance as a food additive.
In Japan, the Ministry of Health and Welfare (MHW) authorized the use of a nitrofuran derivative, namely, nitrofuryl acrylamide (Z-furan), as a bactericidal preservative in ham, sausage, fish paste (kamaboko), soybean curd (tofu), etc. in 1954. A decade later, in 1965, Z-furan and nitrofurazon stepped aside to make way for another variation which had one additional furan nucleus, being chemi cally 2-(2-furyl)-3-(5-nitro-2-furyl) acrylamide or furylfuramide (AF-2) (Fig. 1) .
As regards the safety of this compound, however, questions have been raised by a food researcher (Gunji 1968) , by experimental geneticists (Tajima and Onimaru 1973; Tonomura and Sasaki 1973; Kondo and Ichikawa-Ryo 1973) , by a clinician (Takahashi et al. 1974 ) and by a cancer epidemiologist (Hirayama 1973 ). The present author also had an opportunity to conduct a wide-range survey of the data upon which MHW relied in deciding to authorize the use of AF-2. As a result of statistical analyses of these data, several mistakes were discovered by the present author in regard to the conclusion concerning the safety of AF-2 as a food additive.
MATERIALS AND METHODS

Materials.
The toxicity of AF-2 has been studied by Izeki 
RESULTS
There are two groups of data on toxicological research on AF-2. The first group is composed of Izeki's and Aiso's data, which were reported in the earlier stage of research on AF-2. The second group is that by Miyaji, on which MHW determination of the maximal safe dose of AF-2 is based. These two groups of data are discussed separately.
Data prior to Miyaji's
Chronic toxicity in rats fed diet containing 0.5 mg, 5 my and 50 my of AF-2 per kg body weight for 6 months (Izeki 1961) As Izeki mentioned, the body weight of rats fed AF-2 showed a significant degree of decrease in comparison with the control group ( Fig. 2 and Table 2) . One important fact which the original author missed is that the net weight of the liver increased in accordance with the increase in the amount of AF-2 given as (Izeki) shown in Fig. 3 and Table 3 , while the ratio of the liver to the body weight in the 0.5 mg/kg group is lower than that of the control group from the very beginning.
Chronic toxicity in rats fed diet containing 0.001, 0.005, 0.01 and 0.02 per cent of AF-2 for one year (Aiso et al. 1962 (Aiso et al. , 1964 Although the original authors were aware of the temporal decrease of body Fig. 3 . Graphical estimation of no-ill effect point of AF-2 on increase of the liver weight (Izeki) . To three points of dosage an exponential curve was fitted both in male and female groups. Horizontal lines through the value of the control group crosses this curve in 0.05 mg/kg point of AF-2, giving the estimated value of no-ill effect point. Another important fact which the original authors missed is that the ratio of spleen weight to body weight was significantly higher in the 0.001 and 0.005 per cent groups than in the control group, but not in the 0.01 and 0.02 per cent groups.
As the net weight of the spleen is not given, further analysis of this fact is not possible. Because 0.001 per cent AF-2 in diet fed to rats, which corresponded to (Aiso) Mean values of the weight of the organs of five rats both in male and female groups are always higher than those of control groups. Co, control group; C1, 0.001% group. * Significant at the five per cent level .
0.68 mg per kg body weight, produced demonstrable toxic effects, no-effect dosage level of AF-2 in rats must be less than 1/12.5 of the safety dosage level which MHW authorized. Data by Aiso et al. (1962 Aiso et al. ( , 1964 and Yamaoka (1967) are shown in Table 4 , in which the mean weights of liver, spleen and kidney are always larger in the groups fed AF-2 than those in the control group, though the difference between groups was not always significant, probably because of the smallness of the size of smaple groups (usually five animals in one group).
Data by Miyaji
Miyaji (1971) studied on chronic toxicity in rats fed diet containing 0.0125, 0.05 and 0.2 per cent of AF-2 for a maximum of 2 years.
The data published by Miyaji are important, because on these data MHW based its determination of the maximal safe dose of AF-2 for rats. However, as his experiments seem to have many questionable points viewed from the rationality of experimental design, we would like to discuss these problems first.
Propriety of the selection of the lowest dosage level
Miyaji disregarded the positive results of the toxicity experiment performed for the purpose of determining the lowest level of dosage of AF-2 to be given to rats (Izeki 1961; Aiso et al. 1962 Aiso et al. , 1964 , and started from a very high dosage level of AF-2, that is, 0.0125 per cent in diet or 8.5 mg per kg body weight. The FAO/ WHO Committee (1957) advised as follows: "The lowest dose should be so selected that animals receiving it throughout the experiment period will be expected to show no discernible ill-effects." According to this advice , the lowest dosage level to be used by Miyaji should have had to be less than 0.05 mg per kg, or at most, less than 0.5 mg per kg body weight , as will be stated later.
Effective duration of the experiment The FAO/WHO Committee (1957) also stated as follows: It is customary to Fig. 4 . Situation of raising animals (Miyaji) . In Expt. R-5, each group consisted of 30 rats at the start; 4-5 months thereafter, 10 rats in each group were sacrificed , respectively, for necropsy, leaving 20 rats in each group.
Only one rat in the control group survived 24 months after the start, and all the other rats of all the groups died during this experimental period, leaving no survival in the 0.0125% group. In Expt. R-5' each group consisted of 30 rats at the start. Except 5 rats in each group which were sacrificed for necropsy 4 months later, the majority of all the groups died during the experimental period of 24 months, leaving only 3 survivals in the control group and 6 survivals in the 0.0125% group.
terminate long term experiments on rats at the end of two years, since this is usually considered to cover the major portion of their life span. However, in the case of Miyaji's experiment which was continued for two years, the number of rats which survived after two years was only 4 among 45 in the control group, and 6 among 45 in the 0.0125 per cent group. Most rats in the 0.05 per cent group and 0.2 per cent group died within a period of one and a half years. Rats in each dosage level group tended to decrease in number sharply after one year, owing to sampling for autopsy or death. From this point of view compari son can be made only up to the extent of one year at the most, as about 70 per cent of the rats survived for this length of time (Fig. 4) .
The weight of liver for 12 months
The body and organ weights of rats fed diet containing 0.0125 per cent AF-2 for 12 months are given in Table 5 , cited from Miyaji's paper. Figs. 5 and 6 show the liver weight and ratio of liver weight to body weight for the above group and . The ratio of the weight of the liver and the testis to body weight of rats fed diet containing 0.0125% AF-2 (G2) and the controls (G1). Since the initial body weight of the control group is smaller by about 10% compared to the AF-2 group, only the ratios of the organs were taken into consideration. The ratio of the liver is markedly increased, while that of the testis is decreased compared to the control.
the control group. It is clear that the 0.0125 per cent group shows higher value than does the control group in both liver weight and ratio of liver weight to body weight (significant at the 5 per cent level). The ratios of organ weight to body weight are given in the parentheses.
The weight of the testis for 12 months A graph of the data (Figs. 5 and 6) for the one year test reveals the existence of a larger dispersion in the weights of the 0.0125 per cent and the 0.05 per cent groups compared with the control group, which is statistically significant.
On the other hand, it is confirmed by statistical analysis that mean values of the ratios of testis to body weight in the 0.0125 per cent, 0.05 per cent and 0.2 per cent groups are all significantly lower than the mean value of the control group. As against this, the net weight of testis in the 0.0125 per cent group shows no significant mean difference. It was discovered that this was because of the low mean of initial body weights in the control group. With regard to liver weight as well as to testis weight, 0.0125 percent of AF-2 in diet is not, by any means, no-effect dosage level for rats.
Data for two year period and possible mean difference Nevertheless Miyaji neglected this one year result without presenting any reason in his report, and derived his final conclusion depending on data for the two-year period as follows: "In the present experiments, neither atrophy nor degeneration of the testis in rats and mice was caused by administration of furylfuramide. In addition to these observations, as rats and mice fed on 0.0125 per cent furylfuramide diet could live for two years and there was no difference from the control animals in weight of the liver and survival rate, this concentration The mean value of three experiments decreases linearly against the logarithm of the time until 30 min suggesting that the degradation of AF-2 continues longer than Miyaji's conclus ion. Fig. 7 . Decrease in mutagenicity of AF-2 added to homogenate of rat liver. Means of triplicated experiments (from Shokuhin Eisei Kenkyu 1973). In the original report a standard of q) mm difference in the width of bacteria-free zones was adopted, above which mutagenicity was regarded as positive. However, in this figure it was suggested that a detectable limit of 1 mm would be more appropriate.
However, the value of rec assay from three experiments decreases almost linearly against the logarithm of time at least for 30 min, as is shown in Fig. 7 . Moreover, the blood shows relatively high value of rec assay at least 2 hr after administration of AF-2 in the rats in the dose of 8.5 mg per kg body weight as shown in Table 8 .
DISCUSSION
The acceptability of AF-2 as a food additive will be discussed from two aspects: From its pharmacological properties which are estimated from chemical structure and from its toxicological properties which are determined experimen tally from effectiveness/safety relationship. In case of 0.042 mg/kg there is no increase of the potency within 4 hr. However, in cases of 8.5 mg/kg the potency 2.00 increases to 3.50 after 2 hr. In case of 100 mg/kg 1.50 increases only to 1.75 after 2 to 4 hr. Probably the conclusion is not definite because of unstability of technique and small sample size.
Pharmacological properties
Pharmacology of AF-2 will be approached from the sides of nitrofuran and acrylamide derivative. The former has been mentioned considerably in the research of AF-2, while the latter has been completely neglected.
AF-2 as a nitrofuran derivative
In 1944 Dodd and Stilhnan reported that 5-nitro-furyl compounds had a strong bactericidal property. Since then a few kinds of nitrofuran derivatives have been used in special instances by doctors in the treatment of certain diseases . Nitrofurazon, for example, is administered externally to treat infectious skin diseases. Nitrofurantoin is administered either orally or by injection for persistent infectious diseases of the urinary tract. Because of the difficulty of absorption , furazolidon is administered orally only for bacterial and protozoan diseases of the intestine. While both the external and internal applications of these medicines may provoke allergic reactions, the latter is especially dangerous , since it may damage the reproduction process. The user is warned to watch out for harmful side effects on spermatogenesis (Nelson and Bunge 1957) and on foetuses in the case of pregnant female. Nitrofurantoin, which is excreted through the kidneys, has a tendency to accumulate in high concentrations in the blood of patients with damaged kidneys, leading to such diseases as polyneuritis (Toole and Parrish 1973) , liver damage (Murphy and Innis 1968) and ephemeral pneumonia. In addition , furazolidon has been known to inhibit monoamine oxidase in the body, giving rise to nervous symptoms (Palm et al. 1967) .
It has been known that the bactericidal action of 5-nitrofuran derivatives influences cell nucleic acid. This is presumable from the fundamental biological nature of its action on bacteria and evident from observation of organic damage in small animals.
In 1956 it was learned that X-rays sever and scatter chromosomes in cell nuclei, and the same type of action was found by Payne et al. (1956) to occur as a result of the use of nitrofuran derivatives. Szybalski and Nelson (1954) reported the phenomenon of cross resistance of strains to X-ray irradiation and to nitrofuran derivatives. In 1964 Zampieri and Greenberg discovered that the production of mutations in bacteria, known to be a result of exposure to X-ray or ultraviolet rays since 1954, also resulted from the use of nitrofuran derivatives. Endo et al. (1963) revealed that nitrofuran derivatives act to obstruct the synthesis of nucleic acid in a manner similar to X-ray and ultraviolet rays (their adverse effects on nucleic acid synthesis had been known since 1953). McCalla et al. (1971) reported that strains resistant to nitrofurazon are variants which lack nitrofurazon reductase.
On September 22, 1973, a conference of geneticists in Japan declared AF-2 to be a mutagen on the basis of the fact that it caused rapid mutations in coli bacilli, yeast and silkworms. Tonomura and Sasaki (1973) confirmed that AF-2 definitely caused chromosome abnormalities in human skin cultures. Kondo and Ichikawa-Ryo (1973) showed that AF-2 contained in tofu and fish sausage, initially creating bacteria-free zones, gives rise to mutations which actually foster the growth of coli bacilli colonies even in the absence of special nutrients. In comparison, tofu manufactured according to "traditional" techniques, namely, using no AF-2, was conspicuously free of this mutant-caused growth. Recently Tutikawa and Kada (1974) proved mutagenicity of AF-2 on coli bacilli injected in the peritoneal cavity of rats fed diet containing AF-2. These results suggest that AF-2 absorbed from the intestine is not completely inactivated in the liver. Satomi (1974) proved the increase of cytotoxicity by cultured cells after incubation of AF-2 in liver homogenate and Kada (1973) also proved the generation of mutagenicity of AF-2 by the rec assay method after incubation of AF-2 in liver homogenate.
Against such disclosure of facts which seemingly mean the mistake of the Government, MHW replied with two kinds of evidence to prove its safety. One is the experiment on malformation and reproduction which was performed by Miyaji (1971) . In this experiment, the number of animals is as small as 40. It must be remembered that zero incidence of malformation in 40 animals only assures statis tically that the estimated upper limit of malformation incidence in the population is 9 per cent, the confidence coefficient being 95 per cent. Increase of the variance of the weight of the testis or the apparent decrease of the weight of the testis in the 0.0125 per cent group rather makes us distrustful of the experiment on reproduction and malformation above cited.
In August 1973, a Symposium on Carcinogens was held in Tokyo by the Japan Cancer Association. Hirayama (1973) reported a fairly high correlation (r=0.75) between the consumption of fish sausage and the incidence of cancer of the liver in twelve districts in Japan (limited to people over 40 years of age). In August 1974, Ikeda, National Institute of Hygiene, proved carcinogenicity of AF-2 in mice.
AF-2 as an acrylamide derivative
Acrylamide as a monomer is polymerized to acrylresin, which has been produced industrially on a large scale since about 1950 and used widely in the world. While acrylresin is itself biologically inactive, its basic constituent, acrylamide, was reported as a toxic agent in 1952 by the American Cyanamid Company, the first company which started to produce this substance on a large scale.
Acrylamide provokes severe dermatitis and acts as a strong central and peri pheral nerve poison. The case of acrylamide poisoning in human being is cited in Patty's handbook titled "Industrial Hygiene and Toxicology" (1964) in the form of a personal communication from Golz (1955) . Kuperman (1958) also described several cases of poisoning, but the details were not given. The first detailed report of injuries resulting from contact with acrylamide was issued in 1960 by Japanese doctors, Fujita et al. They reported that 10 out of 18 workers handling acrylamide manifested signs of suffering from damage to the skin and central and peripheral nervous systems. Six cases of aerylamide poisoning were also reported in the United Kingdom by Garland (1967) . Kuperman (1958) and McCollister et al. (1964) clarified the nature of acrylamide injury to the central nervous system through their excellent animal experiments . Kuperman found that intoxication occurred following administration of a definite amount of acrylamide after a definite latent period , without regard to the oral, subcutaneous or intravenous route, and is characterized by ataxia and cramp . According to him the locus of affection might be the midbrain , especially the tegmentum. McCollister et al. (1964) showed that administration of a larger amount shortened the latent period prior to the manifestation of intoxication . They noticed that ataxia was not necessarily of central origin , but of peripheral nature. Hashimoto and Aldridge (1970) clarified that ataxia was not provoked after some modification of the structure of acrylamide at the site of amide radical . However, no reports on the modification of its structure at the position of 3 -Ccould be found in literature.
A strange illness came to be seen from some years ago among tofu making women who appeared to be drunk, who walked lurchingly and whose speech slurred . Occasionally, there were cases of epilepsy-like convulsions or hallucinations in which the ceiling seemed to be falling . The number of large abnormal cells presumed to belong to the reticulo-endotherial system had increased in the blood of one tofu making wife who died in a state of persistent convulsions , giving rise to the suspicion that systemic cancer had developed (Takahashi et al . 1974 
